A proteomic signature that reflects pancreatic beta-cell function.

AIM:Proteomics has the potential to enhance early identification of beta-cell dysfunction, in conjunction with monitoring the various stages of type 2 diabetes onset. The most routine method of assessing pancreatic beta-cell function is an oral glucose tolerance test, however this method is time con...

Full description

Bibliographic Details
Main Authors: Aoife M Curran, Marie Pier Scott-Boyer, Jim Kaput, Miriam F Ryan, Elaine Drummond, Eileen R Gibney, Michael J Gibney, Helen M Roche, Lorraine Brennan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6117012?pdf=render